VTX002

· Oppilan Pharma Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VTX002, covering 2024-11-13 to 2024-11-13. Get the full timeline:

Most recent: Clinical Trial Update: VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis [Phase 2]